Quantbot Technologies LP Increases Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Quantbot Technologies LP grew its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 437.1% during the third quarter, Holdings Channel.com reports. The fund owned 56,560 shares of the real estate investment trust’s stock after acquiring an additional 46,030 shares during the period. Quantbot Technologies LP’s holdings in Sabra Health Care REIT were worth $1,053,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Cetera Advisors LLC boosted its holdings in Sabra Health Care REIT by 996.2% during the 1st quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust’s stock valued at $2,209,000 after acquiring an additional 135,929 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of Sabra Health Care REIT by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 579,110 shares of the real estate investment trust’s stock worth $8,918,000 after purchasing an additional 38,144 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Sabra Health Care REIT by 77.0% in the second quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock valued at $19,824,000 after purchasing an additional 559,800 shares during the period. Cetera Investment Advisers grew its holdings in shares of Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust’s stock valued at $6,007,000 after purchasing an additional 103,413 shares in the last quarter. Finally, Texas Permanent School Fund Corp increased its stake in Sabra Health Care REIT by 22.1% during the 2nd quarter. Texas Permanent School Fund Corp now owns 247,000 shares of the real estate investment trust’s stock worth $3,804,000 after buying an additional 44,639 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Stock Down 1.0 %

Shares of NASDAQ SBRA opened at $18.73 on Friday. The business has a 50-day moving average of $18.64 and a two-hundred day moving average of $16.82. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of 45.68, a price-to-earnings-growth ratio of 2.37 and a beta of 1.25. Sabra Health Care REIT, Inc. has a 1 year low of $12.83 and a 1 year high of $20.03. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). The business had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period last year, the business posted $0.34 EPS. On average, analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.41%. Sabra Health Care REIT’s dividend payout ratio is presently 292.68%.

Wall Street Analyst Weigh In

Several brokerages have commented on SBRA. Truist Financial raised their price target on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank increased their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Finally, Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $17.00 to $20.00 in a research note on Friday, September 13th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.